Design, Synthesis and Biological Evaluation of Novel Pyrimido[4,5-d]pyrimidine CDK2 Inhibitors as Anti-Tumor Agents.

El-Moghazy, Samir M; Ibrahim, Diaa A; Abdelgawad, Nagwa M; Farag, Nahla A H; El-Khouly, Ahmad S

El-Moghazy, Samir M; Ibrahim, Diaa A; Abdelgawad, Nagwa M; Farag, Nahla A H; El-Khouly, Ahmad S.

Afiliação

El-Moghazy SM; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt.

Sci Pharm ; 79(3): 429-47, 2011.

Article em En | MEDLINE | ID: mdl-21886895

Palavras-chave

Anti-tumor; CDK2; Drug Design; Pharmacophore; Pyrimido[4,5-d]pyrimidine

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163380
https://dx.doi.org/10.3797/scipharm.1103-16

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2011 Tipo de documento: Article

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163380
https://dx.doi.org/10.3797/scipharm.1103-16

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2011 Tipo de documento: Article